从马来西亚分离出的携带CTX-M-65的两株多重耐药奇异变形杆菌的基因组序列
Genome Sequences of Two Multidrug-Resistant Proteus mirabilis Strains Harboring CTX-M-65 Isolated from Malaysia.
作者信息
Yu Choo Yee, Ang Geik Yong, Ngeow Yun Fong, Tee Kok Keng, Yin Wai-Fong, Chan Kok-Gan
机构信息
Division of Genetics and Molecular Biology, Institute of Biological Sciences, University of Malaya, Kuala Lumpur, Malaysia.
Integrative Pharmacogenomics Institute (iPROMISE), Universiti Teknologi MARA, Kuala Lumpur, Malaysia.
出版信息
Genome Announc. 2016 Nov 17;4(6):e01301-16. doi: 10.1128/genomeA.01301-16.
Abstract
Proteus mirabilis is an opportunistic nosocomial pathogen that is commonly associated with urinary tract infections. Here, we present draft genome sequences of two multidrug-resistant P. mirabilis strains, isolated from urine samples in Malaysia, that harbored a CTX-M-type extended-spectrum β-lactamase-encoding gene, as well as a repertoire of other antimicrobial-resistant determinants.
摘要
奇异变形杆菌是一种机会性医院病原体，通常与尿路感染有关。在此，我们展示了从马来西亚尿液样本中分离出的两株耐多药奇异变形杆菌菌株的基因组草图序列，这些菌株携带一个CTX-M型超广谱β-内酰胺酶编码基因以及一系列其他抗微生物耐药决定因素。
相似文献
1
Genome Sequences of Two Multidrug-Resistant Proteus mirabilis Strains Harboring CTX-M-65 Isolated from Malaysia.
Genome Announc. 2016 Nov 17;4(6):e01301-16. doi: 10.1128/genomeA.01301-16.
2
Extended-spectrum β-lactamase-producing Proteus mirabilis with multidrug resistance isolated from raw chicken in Singapore: Genotypic and phenotypic analysis.
J Glob Antimicrob Resist. 2019 Dec;19:252-254. doi: 10.1016/j.jgar.2019.10.013. Epub 2019 Oct 19.
3
Dissemination of Proteus mirabilis isolates harboring CTX-M-14 and CTX-M-3 beta-lactamases at 2 hospitals in Taiwan.
Diagn Microbiol Infect Dis. 2006 Feb;54(2):89-94. doi: 10.1016/j.diagmicrobio.2005.09.005. Epub 2006 Jan 9.
4
Detection of TEM and CTX-M genes from ciprofloxacin resistant Proteus mirabilis and Escherichia coli isolated on urinary tract infections (UTIs).
Microb Pathog. 2018 Aug;121:123-130. doi: 10.1016/j.micpath.2018.05.024. Epub 2018 May 17.
5
Regional outbreak of CTX-M-2 β-lactamase-producing Proteus mirabilis in Japan.
J Med Microbiol. 2012 Dec;61(Pt 12):1727-1735. doi: 10.1099/jmm.0.049726-0. Epub 2012 Aug 30.
6
First report of an OXA-48-producing multidrug-resistant Proteus mirabilis strain from Gaza, Palestine.
Antimicrob Agents Chemother. 2015 Jul;59(7):4305-7. doi: 10.1128/AAC.00565-15. Epub 2015 Apr 20.
7
[The incidence of extended spectrum beta-lactamases in Proteus mirabilis strains isolated in 2007-2009].
Przegl Epidemiol. 2010;64(3):395-8.
8
[Study of resistance mechanism on cefotaxime resistant Proteus mirabilis isolated from clinical specimens and its clinical background].
Kansenshogaku Zasshi. 2004 Jan;78(1):1-9. doi: 10.11150/kansenshogakuzasshi1970.78.1.
9
Genetic characteristic of class 1 integrons in proteus mirabilis isolates from urine samples.
Biomedicine (Taipei). 2017 Jun;7(2):9. doi: 10.1051/bmdcn/2017070202. Epub 2017 Jun 14.
10
Characterization of CTX-M-140, a Variant of CTX-M-14 Extended-Spectrum β-Lactamase with Decreased Cephalosporin Hydrolytic Activity, from Cephalosporin-Resistant Proteus mirabilis.
Antimicrob Agents Chemother. 2016 Sep 23;60(10):6121-6. doi: 10.1128/AAC.00822-16. Print 2016 Oct.
引用本文的文献
1
First Report of Complete Genome Analysis of Multiple Drug Resistance KUST-1312 Isolate From Migratory Birds in China: A Public Health Threat.
Transbound Emerg Dis. 2024 Oct 3;2024:8102506. doi: 10.1155/2024/8102506. eCollection 2024.
2
Draft Genome of Serogroup O18 Elaborating Phosphocholine-Decorated O Antigen.
Front Cell Infect Microbiol. 2021 Mar 25;11:620010. doi: 10.3389/fcimb.2021.620010. eCollection 2021.
3
Draft Genome Sequences of Proteus mirabilis K1609 and K670: A Model Strains for Territoriality Examination.
Curr Microbiol. 2019 Feb;76(2):144-152. doi: 10.1007/s00284-018-1598-6. Epub 2018 Nov 17.
本文引用的文献
1
Proteus mirabilis urinary tract infection and bacteremia: risk factors, clinical presentation, and outcomes.
J Microbiol Immunol Infect. 2012 Jun;45(3):228-36. doi: 10.1016/j.jmii.2011.11.007. Epub 2012 May 7.
2
Multidrug-resistant Proteus mirabilis bloodstream infections: risk factors and outcomes.
Antimicrob Agents Chemother. 2012 Jun;56(6):3224-31. doi: 10.1128/AAC.05966-11. Epub 2012 Mar 26.
3
The RAST Server: rapid annotations using subsystems technology.
BMC Genomics. 2008 Feb 8;9:75. doi: 10.1186/1471-2164-9-75.
4
Proteus mirabilis bloodstream infections: risk factors and treatment outcome related to the expression of extended-spectrum beta-lactamases.
Antimicrob Agents Chemother. 2005 Jul;49(7):2598-605. doi: 10.1128/AAC.49.7.2598-2605.2005.
5
Classification, identification, and clinical significance of Proteus, Providencia, and Morganella.
Clin Microbiol Rev. 2000 Oct;13(4):534-46. doi: 10.1128/CMR.13.4.534.
Zotero 插件